Harlow John B. Jr. (CIK 2095554) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-13). Recent activity: Sell ESPR (424,536 shares), Buy ESPR (424,536 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | Esperion Therapeutics, Inc. (ESPR) | Chief Commercial Officer | Sell | 424,536 | $0 |
| 2025-12-08 | Esperion Therapeutics, Inc. (ESPR) | Chief Commercial Officer | Buy | 424,536 | $0 |
Source: SEC Form 4 filings · as of 2026-07-13